1. Clinical characteristics and hematological parameters associated with disease severity in <scp>COVID</scp> ‐19 positive pregnant women undergoing cesarean section: A <scp>single‐center</scp> experience
- Author
-
Merve Vay, Baris Arslan, Emre Destegul, Ilhan G. Bicer, Tuna Sahin, and Okan Dilek
- Subjects
medicine.medical_specialty ,Aspartate transaminase ,Single Center ,Severity of Illness Index ,Procalcitonin ,Pregnancy ,Internal medicine ,medicine ,Humans ,Retrospective Studies ,biology ,Receiver operating characteristic ,Cesarean Section ,SARS-CoV-2 ,business.industry ,COVID-19 ,Obstetrics and Gynecology ,medicine.disease ,Confidence interval ,ROC Curve ,Alanine transaminase ,Relative risk ,biology.protein ,Female ,Pregnant Women ,business - Abstract
Aim Method Results Conclusion The study aimed to describe clinical characteristics and outcomes of pregnant women with COVID‐19 undergoing cesarean section, and evaluated the association of blood values at admission with severe COVID‐19 disease in this group of patients.We retrospectively analyzed the clinical data of 110 patients infected with COVID‐19 who underwent cesarean section at Adana City Education and Research Hospital in Turkey. The COVID‐19 severity of the patients was classified as either severe or nonsevere disease according to World Health Organization of COVID‐19 clinical management guidance. We compared blood values, clinical characteristics, and outcomes between severe and nonsevere patients. Receiver operating characteristics (ROC) curves analyses and area under the ROC curve (AUC) value was calculated to evaluate the predictive value of blood parameters on the COVID‐19 severity.Of the 110 women, 12 were severe cases. Severe patients had higher ferritin, neutrophil‐to‐lymphocyte ratio (NLR), lactate dehydrogenase (LDH), alanine transaminase (ALT), aspartate transaminase (AST), and procalcitonin levels on admission (p
- Published
- 2021